Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (171-180 of 263) with videos related to

Pageof 27
Sort By:
Medicina Clinica|September 17, 1988
[Human immunodeficiency virus antigens and antibodies in parenteral drug addicts: correlations with a clinical study]R Muga, J Tor, V Soriano, et al.
The Journal of Infectious Diseases|April 16, 1998
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patientsC Tural, J Romeu, G Sirera, et al.
AIDS (London, England)|April 19, 2000
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppressionL Ruiz, J Martinez-Picado, J Romeu, et al.
Journal of Viral Hepatitis|September 15, 2011
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitorsS Franco, R Bellido, E Aparicio, et al.
HIV Medicine|January 10, 2013
Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeksA M Mills, A Antinori, B Clotet, et al.
AIDS (London, England)|June 10, 1998
Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 yearsA Arnó, L Ruiz, M Juan, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
Journal of Viral Hepatitis|March 5, 2003
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patientsC Tural, D Fuster, J Tor, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
AIDS Care|August 30, 2008
Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefsC R Fumaz, J A Muñoz-Moreno, J Moltó, et al.
Pageof 27

Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
Medicina Clinica|September 17, 1988
[Human immunodeficiency virus antigens and antibodies in parenteral drug addicts: correlations with a clinical study]R Muga, J Tor, V Soriano, et al.
The Journal of Infectious Diseases|April 16, 1998
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patientsC Tural, J Romeu, G Sirera, et al.
AIDS (London, England)|April 19, 2000
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppressionL Ruiz, J Martinez-Picado, J Romeu, et al.
Journal of Viral Hepatitis|September 15, 2011
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitorsS Franco, R Bellido, E Aparicio, et al.
HIV Medicine|January 10, 2013
Neurological and psychiatric tolerability of rilpivirine (TMC278) vs. efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeksA M Mills, A Antinori, B Clotet, et al.
AIDS (London, England)|June 10, 1998
Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 yearsA Arnó, L Ruiz, M Juan, et al.
AIDS (London, England)|June 6, 2000
The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study TeamC Katlama, B Clotet, A Plettenberg, et al.
Journal of Viral Hepatitis|March 5, 2003
Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patientsC Tural, D Fuster, J Tor, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 12, 1998
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study GroupA N Phillips, C Katlama, S Barton, et al.
AIDS Care|August 30, 2008
Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefsC R Fumaz, J A Muñoz-Moreno, J Moltó, et al.
Pageof 27